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Abstract
Piperazirum, isolated from Arum palaestinum Boiss, was originally assigned as r-3,c-5-diisobutyl-c-6-isopropylpiperazin-2-one.
The reported structure was synthesised diastereoselectively using a key nitro-Mannich reaction to set up the C5/C6 relative stereo-
chemistry. The structure was unambiguously assigned by single crystal X-ray diffraction but the spectroscopic data did not match
those reported for the natural product. The structure of the natural product must therefore be revised.
Introduction
The nitro-Mannich reaction (or aza-Henry reaction) has been
developed to a standard where the product β-nitroamines 1 are
now privileged building blocks. In part this is due to the
complementary synthetic flexibility available from the two
different nitrogen atom oxidation states (Scheme 1) [1]. They
have been used to synthesise many nitrogen-containing func-
tional groups including α-amino carbonyls [2,3], peptidomi-
metics [4], natural products [5-10] and many heterocyclic small
molecules [11-24] of importance to drug discovery. Enantiose-
lective reactions have been controlled by asymmetric metal-
centred Lewis acids; chiral hydrogen bond donors, in particular
by the use of asymmetric thiourea organocatalysts, chiral
Brønsted acids, phase-transfer catalysts and Brønsted base cata-
lysts [3,15,25-39]. A large part of our own work in developing
the nitro-Mannich reaction was to demonstrate the preparation
of stereodefined 1,2-diamines [40-45].
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Scheme 2: Retrosynthetic analysis of piperazirum.
Scheme 1: Schematic nitro-Mannich reaction.
As part of a programme aimed at using these 1,2-diamines as
building blocks in target synthesis we focused on the synthesis
of a novel bioactive alkaloid, piperazirum (2, Scheme 2), which
to our knowledge had not been previously synthesised.
Piperazirum was isolated from the leaf extract of Arum palaes-
tinum Boiss and was shown to possess significant cytotoxicity
against cultured tumor cell lines in vitro [46]. Its chemical
structure and relative stereochemistry were elucidated by high
resolution mass spectrometry, infrared, 1D and 2D NMR spec-
troscopy [46]. Retrosynthetically we envisaged that the C-3
stereocentre could be set up by hydrogenation from the less
hindered face of α-iminolactam 3 or α,β-unsaturated lactam 4
(Scheme 2). These heterocycles could be derived from a
common α-keto acid derivative 5 and either diamine 6 or 7, that
could in turn be prepared from β-nitroamine 8 or 9. Each of the
β-nitroamines could be prepared enantioselectively by using our
previously reported methodology [28,43,45] and would allow
elucidation of the absolute stereochemistry of piperazirum (2).
Results and Discussion
The common α-keto acid derivative 5 was easily prepared from
a Grignard reaction of isobutylmagnesium chloride with diethyl
oxalate to give α-keto ester 10 in 94% yield (Scheme 3) [47].
Saponification of 10 with KOH provided α-keto acid 11 in
excellent yield [48], and the corresponding acid chloride 12 was
prepared in situ by treatment with oxalyl chloride [49].
For the synthesis of β-nitroamine 8 we decided to make use of
the reductive nitro-Mannich reaction as the starting nitroalkene
Scheme 3: (a) iBuMgCl, Et2O, −78 °C; (b) KOH, EtOH/H2O, 100 °C;
(c) (COCl)2.
13 is readily available from a Henry reaction [50], imine 14
from the condensation of p-anisidine and isobutyraldehyde, and
the process can easily be made asymmetric [45]. Conjugate ad-
dition of hydride to 13 and subsequent trapping of the nitronate
anion with freshly prepared imine 14 in THF gave β-nitroamine
15 in 64% conversion and a dr of 70:30 (Scheme 4). Quite
frequently β-nitroamines are unstable and susceptible to
retroaddition [43,44]. Formation of the corresponding trifluoro-
acetamide derivative confers stability and allows them to be
purified. Using previously developed conditions to protect the
amine in situ using (CF3CO)2O gave only β-nitroamine 16 as a
single diastereoisomer in a low 15% yield. These results are
consistent with the poor conversions and dr, as well as resist-
ance to trifluoroacetamide protection, we have observed before
from imines derived from α-branched aldehydes such as cyclo-
hexanecarbaldehyde [44].
In cases where trifluoroacetylation fails, it is quite common to
purify the β-nitroamine by rapid column chromatography,
quickly followed by reduction to give the corresponding 1,2-di-
amine. In this case rapid purification of 15 followed by reduc-
tion with Zn/HCl gave the 1,2-diamine 17 as a single diastereo-
isomer in 50% yield (Scheme 4).
With diamine 17 in hand, the reaction with a suitable keto acid
derivative was investigated. We presumed that the nitrogen of
the primary amine would be the more nucleophilic and hence
should react with the more electrophilic carbonyl group – i.e.
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Scheme 4: (a) Li(Et3BH), THF, rt then 14, CF3CO2H, −78 °C, dr 70:30; (b) (CF3CO)2O, Py, CH2Cl2, 0 °C to rt; (c) Zn, 6 M HCl, EtOAc/EtOH, rt.
Scheme 5: (a) Li(Et3BH), CH2Cl2, rt then 19, CF3CO2H, −78 °C, dr >95:5; (b) Zn, 6 M HCl, EtOAc/EtOH, rt, single diastereoisomer; (c) CSCl2, aq
NaHCO3 CH2Cl2/ MeOH, rt.
the ketone – in 10 [51,52]. Attempted formation of 4 by heating
a mixture of 10 and 17 in H2O at 50 °C gave a complicated
mixture of products and attempts under Dean–Stark conditions
in toluene with TsOH gave only recovered starting materials
[53].
In light of this poor result, the alternative route to 2 via
β-nitroamine 9 was investigated. A reductive nitro-Mannich
reaction between nitroalkene 18 [54] and freshly prepared imine
19 in CH2Cl2 followed by rapid flash chromatography gave
β-nitroamine 20 with complete conversion and dr >95:5 [55].
As before immediate reduction with Zn/HCl gave the PMP-
protected diamine 21 in 85% yield as a single diastereoisomer
determined by 1H NMR (Scheme 5).
From a comprehensive series of examples of the reductive
nitro-Mannich reaction, the vast majority of substrates demon-
strate anti-relative stereochemistry [23,44,45]. More direct
proof for 21 was gleaned from the corresponding imidazolidine-
2-thione formed by treatment with thiophosgene to give 22
(Scheme 5). In one dimensional nOe studies irradiation of the
CHNH peak (δ 3.70, 1H, dd, J = 8.4, 5.4 Hz) caused a 3.65%
enhancement of the CHN peak (δ 4.31, 1H, dt, J = 7.9, 5.9 Hz),
indicating a cis-relative stereochemistry between the two
protons, which confirmed the anti-relative stereochemistry of
21. The observed coupling constant between the same two
protons was 8.2 Hz (averaged) and was similar to other
imidazolidine-2-thiones we have prepared that have been
corroborated by single crystal X-ray crystallography [56].
Further stereochemical proof was provided by a single crystal
X-ray structure determination of 2·HCl (vide infra).
We presumed again that the primary amine of 21 would be
more nucleophilic towards a keto acid derivative 5. In order to
obtain a piperazinone of the desired connectivity (23) a keto
acid derivative would be required where the carboxylate car-
bonyl is more reactive than the ketone carbonyl. Two possible
such compounds were considered, acid chloride 12 and
carboxylic acid 11 treated with a suitable coupling agent. Acid
chloride 12 was prepared in situ by treatment of acid 11 with
oxalyl chloride (2.00 equiv) and catalytic DMF. Subsequent
reaction with diamine 21 in the presence of pyridine
(1.20 equiv) and catalytic DMAP over 24 h, according to previ-
ously reported reactions for similar keto acids [49], gave only
the bis-adduct 24 and none of the desired piperazinone 23. By
contrast, the reaction of carboxylic acid 11 with diamine 21, in
the presence of EDC (1.50 equiv) and 1-hydroxybenzotriazole
(1.50 equiv) at rt, gave the desired product 23 in good yield
(Scheme 6) [57]. The double bond geometry was assigned as Z
by NOESY 1H NMR and probably results from steric inhibi-
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Scheme 6: (a) (COCl)2, DMF, CH2Cl2, rt; (b) 21, Py, DMAP, CH2Cl2, rt; (c) EDC, HOBt, THF/CH2Cl2, rt; (d) H2 (1 atm), Pd/C, MeOH, rt; (e) CAN,
MeCN/H2O, 0 °C; (f) 4 M HCl in dioxane, MeCN/Et2O.
Table 1: Comparison of selected 13C NMR chemical shifts of piperazirum, 2 and 2·HCl.
Carbon
atom
piperazirum δc (ppm)
D2O [49]
2 δc (ppm)
DMSO-d6
2 δc (ppm)
CDCl3
2·HCl δc (ppm)
D2O
C-2 175.7 172.5 174.3 169.9
C-3 53.6 56.4 56.9 54.9
C-5 59.7 53.2 53.3 53.9
C-6 60.6 58.1 59.4 56.3
CH2C-3 40.0 41.5 41.1 38.8
CH2C-5 24.6 40.2 40.5 36.3
tion of resonance which would result in the formation of the E
iPr group and the planar amide group during formation of 23.
Reduction of the double bond with hydrogen over palladium on
charcoal gave a single diastereoisomer 25 in quantitative yield.
In one dimensional nOe studies irradiation of H-3 (δ 4.09, 1H,
dd, J = 9.9, 4.5 Hz) caused a 0.17% enhancement of the H-6
signal (δ 3.18, 1H, dd, J = 10.0, 3.5 Hz) with negligible
enhancement of the H-5 signal (δ 3.37, 1H, dt, J = 12.4, 3.1
Hz). Irradiation of H-5 caused a 2.90% enhancement of the H-6
signal and a 0.07% enhancement of the H-3 signal. The nOe
data tentatively suggested that protons H-3, H-5 and H-6 were
all on the same face of the molecule. Deprotection of the PMP
group with CAN gave compound 2. Extensive NMR (COSY,
HMBC and NOESY) and analytical data were consistent with
the structure drawn (2), but the 1H and 13C NMR did not match
that published for piperazirum (Table 1) [46]. The original
authors recorded their NMR data for piperazirum in D2O [58],
but our sample 2 was insoluble. Compound 2 was readily
soluble in DMSO-d6 and CDCl3, but neither gave a satisfactory
match to the reported NMR data. Preparation of 2·HCl allowed Figure 1: X-ray crystal structure of 2·HCl.
the recording of NMR spectra in D2O, but again the chemical
shifts were inconsistent with those reported. Single crystal
X-ray structure determination of 2 proved unambiguously the
assigned structure obtained from spectroscopic data (Figure 1)
[59].
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Conclusion
The rapid synthesis of r-3,c-5-diisobutyl-c-6-isopropyl-
piperazin-2-one has been achieved using an efficient nitro-
Mannich reaction to establish the C-5/C-6 relative stereochem-
istry which in turn controls the formation of the stereocentre at
C-3. Spectrosocpic and single crystal X-ray data have shown
that the reported structure for piperazirum is erroneous and that
the structure of the natural product needs to be revised. While
the reported data point strongly towards piperazirum having the
same connectivity as 2, it is not clear which of the three alter-
native diastereomers corresponds to the natural product. In view
of the lack of natural material, further chemical synthesis,
guided by GIAO chemical shift prediction, is currently
underway in an effort to elucidate the correct structure for
piperazirum. In addition the determination of further biological
activity of 2 and its diastereoisomers will be investigated.
Experimental
Unless otherwise stated, all reactions were carried out under an
atmosphere of nitrogen. All glassware was flame dried and
allowed to cool under a stream of nitrogen before use. Cooling
to 0 °C was effected using an ice–water bath. Cooling to
temperatures below 0 °C was effected using dry ice–acetone
mixtures. Reactions were monitored by thin layer chromatog-
raphy (TLC) using 0.25 mm silica precoated plastic plates with
fluorescent indicator. Sheets were visualised using ultraviolet
light (254 nm) and/or anisaldehyde or KMnO4 solutions, as
appropriate. Removal of solvents (in vacuo) was achieved using
a water aspirator and rotary evaporators. Flash column chroma-
tography was performed using silica gel 60, 40–63 μm.
Commercial solvents and reagents were used as supplied or
purified in accordance with standard procedures [60]. Diethyl
ether (Et2O), tetrahydrofuran (THF), dichloromethane (CH2Cl2)
and toluene (PhMe) were obtained from a solvent tower, where
degassed solvent was passed through two columns of activated
alumina and a 7 micron filter under 4 bar pressure. All NMR
samples were made as dilute solutions of CDCl3 unless other-
wise stated. All chemical shifts (δ) are reported in parts per
million (ppm) relative to residual solvent peaks except in D2O
where they are relative to dioxane (D2O) 1H 3.75 ppm and 13C
67.2 ppm. Multiplicities for 1H coupled signals are denoted as
s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet,
m = multiplet. Coupling constants (J) are reported in Hertz. 13C
multiplicities were assigned using a DEPT sequence. Where
appropriate, HMQC, COSY, HMBC and NOE experiments
were carried out to aid assignment. Melting points are uncor-
rected.
(E)-4-Methoxy-N-(3-methylbutylidene)aniline (19): To a
mixture of p-anisidine (123 mg, 1.00 mmol) and basic alumina
(1.00 g) in CH2Cl2 (5 mL) at −78 °C was added isovaleralde-
hyde (107 µL, 1.00 mmol) and the mixture stirred for 1 h, then
warmed to rt, filtered and evaporated in vacuo to give crude
imine 19 (182 mg, 95%) as a colourless oil that was used imme-
diately without further purification; 1H NMR (600 MHz) δ 1.02
(d, J = 6.7, 6H, CH3), 2.04 (sept, J = 6.7, 1H, CH(CH3)2), 2.34
(dd, J = 7.0, 5.4, 2H, CH2), 3.80 (s, 1H, OCH3), 6.87 (app. d, J
= 8.9, 2H, ArH), 7.02 (app. d, J = 8.9, 2H, ArH), 7.86 (t, J =
5.4, 1H, N=CH); 13C NMR (150 MHz) data were in agreement
to that reported [61].
(3R*,4S*)-N4-(4-Methoxyphenyl)-2,6-dimethylheptane-3,4-
diamine (21): To a solution of nitroalkene 18 (202 mg,
2.00 mmol), in CH2Cl2 (12.0 mL) was added Superhydride®
(2.20 mL, 1 M in THF, 2.20 mmol) and the mixture stirred for
15 min at rt. The mixture was cooled to −78 °C before the drop-
wise addition of a solution of freshly prepared imine 19
(564 mg, 4.00 mmol) in CH2Cl2 (12.0 mL). The reaction was
stirred for 10 min before the dropwise addition of a solution of
CF3CO2H (460 µL, 6.00 mmol) in CH2Cl2 (4.0 mL). The reac-
tion was stirred for 1 h and then quenched with brine (20 mL) at
−78 °C, warmed to rt and extracted with Et2O (3 × 20 mL). The
combined organics were dried (MgSO4) and evaporated in
vacuo to give crude β-nitroamine 20, that was purified by
column chromatography (petrol ether/Et2O 4:1). Subsequent
reaction with 6 M HCl (6.60 mL, 40.0 mmol) and Zn dust
(1.30 g, 20.0 mmol) and purification by flash column chroma-
tography (CH2Cl2/MeOH 10:1) gave diamine 21 (452 mg,
85%) as a brown oil; Rf 0.50 (CH2Cl2/MeOH 10:1); IR νmax
(thin film): 3374 (br, N-H), 2955 (w, C-H), 1618 (w), 1508 (s,
C=C), 1465 (m), 1441 (w), 1385 (w), 1366 (w), 1292 (w), 1238
(s), 1179 (w), 1154 (w), 1038 (m), 816 (m), 752 (s) cm−1; 1H
NMR (600 MHz) δ 0.90 (d, J = 6.5, 3H, CH3), 0.92 (d, J = 6.7,
3H, CH3), 0.99 (d, J = 6.6, 6H, CH3), 1.21 (m, 1H, CH2), 1.35
(m, 1H, CH2), 1.59 (m, 1H, CH(CH3)2), 1.80 (m, 1H,
CH(CH3)2), 2.53 (dd, J = 9.1, 2.7, 1H, CHNH2), 3.52 (m, 1H,
CHNH), 3.73 (s, 3H, OCH3), 6.57 (app. d, J = 8.9, 2H, ArH),
6.76 (app. d, J = 8.9, 2H, ArH); 13C NMR (150 MHz) δ 19.6
(CH3), 20.6 (CH3), 21.7 (CH3), 24.1 (CH3), 24.7 (CH(CH3)2),
31.4 (CH(CH3)2), 37.2 (CH2), 52.9 (CHNH), 55.8 (OCH3),
59.1 (CHNH2), 114.4 (CH arom.), 115.0 (CH arom.), 142.3 (Cq
arom.), 151.6 (Cq arom.); MS (EI+) m/z: 264 (M+, 5%), 192
(M+ − (CH3)2CHCHNH2, 100%); HRMS m/z: calcd for
C16H28N2O, 264.2196; found, 264.2201.
(5S*,6R*,Z)-5-Isobutyl-6-isopropyl-4-(4-methoxyphenyl)-3-
(2-methylpropylidene)piperazin-2-one (23): To a solution of
diamine 21 (61 mg, 0.23 mmol) in THF (5 mL) was added
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydro-
chloride (EDC, 67 mg, 0.35 mmol) and 1-hydroxybenzo-
triazole hydrate (47 mg, 0.35 mmol) followed by a solution of
keto acid 11 (30 mg, 0.23 mmol) in CH2Cl2 (5 mL) at rt. The
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mixture was stirred for 24 h, then diluted with CH2Cl2 (20 mL)
and washed with brine (10 mL). The combined organic phases
were dried (MgSO4), evaporated in vacuo and purified by flash
column chromatography (petrol ether/EtOAc 7:3) to give piper-
azinone 23 (57 mg, 69%) as a brown solid; mp 152–153 °C; Rf
0.30 (petrol ether/EtOAc 7:3); IR νmax (thin film): 3209 (br,
N-H), 2956 (w, C-H), 1671 (s, C=C), 1622 (s), 1499 (s), 1464
(m), 1442 (m), 1409 (m), 1384 (m), 1366 (m), 1331 (m), 1283
(m), 1241 (s), 1180 (m), 1153 (m), 1037 (m), 826 (s), 767 (m)
cm−1; 1H NMR (600 MHz) δ 0.68 (d, J = 6.6, 3H, CH3), 0.79
(d, J = 6.6, 3H, CH3), 0.88 (d, J = 6.6, 3H, CH3), 0.93 (d, J =
6.5, 3H, CH3), 0.95 (d, J = 6.7, 3H, CH3), 1.07 (d, J = 6.5, 3H,
CH3), 1.07 (m, 1H, CH2), 1.55 (m, 1H, CH2), 1.55 (m, 1H,
CH(CH3)2), 1.94 (m, 1H, CH(CH3)2), 2.43 (m, 1H, CH(CH3)2),
3.18 (dd, J = 10.3, 3.6, 1H, CHNH), 3.53 (br. d, J = 12.2, 1H,
NCHCH2), 3.76 (s, 3H, OCH3), 5.89 (br. s, 1H, NH), 6.48 (d, J
= 10.6, 1H, =CH), 6.78 (app. d, J = 8.8, 2H, ArH), 6.89 (app. d,
J = 8.8, 2H, ArH); 13C NMR (150 MHz) δ 17.9 (CH3), 19.4
(CH3), 20.3 (CH3), 21.5 (CH3), 22.2 (CH3), 23.7 (CH3), 24.1
(CH(CH3)2), 26.4 (CH(CH3)2), 29.0 (CH(CH3)2), 34.4 (CH2),
55.4 (OCH3), 58.0 (CHNH), 58.8 (NCHCH2), 114.3 (CH
arom.), 122.0 (CH arom.), 129.7 (CH=Cq), 140.0 (Cq=CH),
143.4 (Cq arom.), 154.3 (Cq arom.), 164.3 (C=O); MS (EI+) m/
z: 359 (MH+, 100%), 343 (12%), 192 (13%); HRMS m/z: calcd
for C22H35N2O2, 359.2693; found, 359.2678.
(3R*,5S*,6R*)-3,5-diisobutyl-6-isopropyl-4-(4-meth-
oxyphenyl)piperazin-2-one (25): To a solution of piper-
azinone 23 (170 mg, 0.470 mmol) in MeOH (10 mL) was added
palladium on carbon (50 mg, 10% by weight, 0.047 mmol) and
the mixture was flushed with hydrogen, then stirred under a
hydrogen atmosphere (balloon) at rt. After the piperazinone
starting material was consumed (TLC, 4 h) the mixture was
filtered through celite®, washed with CH2Cl2 (20 mL) and
evaporated in vacuo to give crude piperazinone that was puri-
fied by flash column chromatography (petrol ether/Me2CO 4:1)
to give piperazinone 25 (170 mg, 99%) as a colourless oil; Rf
0.50 (petrol ether/Me2CO 4:1); IR νmax (thin film): 3207 (br,
N-H), 2954 (m, C-H), 1658 (s, C=O), 1505 (C=C), 1465 (m),
1367 (m), 1242 (s), 1180 (m), 1039 (m), 827 (m), 788 (m), 733
(m) cm−1; 1H NMR (600 MHz) δ 0.70 (d, J = 6.5, 3H, CH3),
0.77 (d, J = 6.7, 3H, CH3), 0.90 (d, J = 6.7, 3H, CH3), 0.97 (d, J
= 6.5, 3H, CH3), 0.98 (d, J = 6.8, 3H, CH3), 1.03 (d, J = 6.5,
3H, CH3), 1.03 (m, 1H, CHCHCH2), 1.55 (m, 1H, CHCHCH2),
1.55 (m, 1H, O=CCHCH2), 1.55 (m, 1H, CHCH(CH3)2), 1.84
(m, 1H, O=CCHCH2), 1.92 (m, 1H, O=CCHCH2CH(CH3)2),
2.06 (m, 1H, CHCHCH2CH(CH3)2), 3.18 (dd, J = 10.0, 3.5,
1H, NHCH), 3.37 (dt, J = 12.4, 3.1, 1H, NHCHCHN), 3.77 (s,
3H, OCH3), 4.09 (dd, J = 9.9, 4.5, 1H, O=CCH), 6.02 (br. s,
1H, NH), 6.80 (app. d, J = 8.9, 2H, ArH), 6.91 (app. d, J = 8.9,
2H, ArH); 13C NMR (150 MHz) δ 18.0 (CH3), 19.5 (CH3), 21.5
(CH3), 21.6 (CH3), 23.3 (CH3), 23.4 (CHCHCH2CH(CH3)2),
2 3 . 7  ( C H 3 ) ,  2 4 . 7  ( O = C C H C H 2 C H ( C H 3 ) 2 ) ,  2 9 . 2
(NHCHCH(CH3)2), 34.7 (CH2CHCH), 44.0 (CH2CHC=O),
55.4 (OCH3), 57.2 (NCHC=O), 58.4 (NCHCH), 58.5 (NHCH),
114.5 (CH arom.), 122.6 (CH arom.), 146.2 (CH arom.), 154.3
(CH arom.), 173.9 (C=O); MS (EI+) m/z: 360 (M+, 15%), 303
(18%), 192 (100%); HRMS m/z: calcd for C22H36N2O2,
360.2771; found, 360.2774.
(3R*,5S*,6R*)-3,5-diisobutyl-6-isopropylpiperazin-2-one
(2): To a solution of piperazinone 25 (320 mg, 0.880 mmol) in
MeCN (10 mL) at 0 °C was added a solution of CAN (2.08 g,
3.52 mmol) in H2O (10 mL) dropwise over 3 min. The solution
turned from pale yellow to dark orange. The mixture was stirred
at 0 °C for 2 h, over which time the solution became light
orange. Water (30 mL) was then added and the mixture
extracted with EtOAc (3 × 20 mL), washed with saturated
aqueous NaHCO3 (40 mL), dried (MgSO4) and evaporated in
vacuo to give crude piperazinone that was purified by flash
column chromatography (petrol ether/Me2CO 3:2) to give
piperazinone 2 (91 mg, 41%) as a brown oil; Rf 0.53 (petrol
ether/Me2CO 3:2); IR νmax (thin film): 3209 (w, N-H), 2955
(C-H), 1658 (s, C=O), 1467 (m), 1367 (m), 1165 (w), 918 (w),
722 (w) cm−1; 1H NMR (600 MHz, CDCl3) δ 0.89 (d, J = 6.6,
3H, C-3CH2CHCH3), 0.90 (d, J = 6.2, 3H, C-5CH2CHCH3),
0.91 (d, J = 5.6, 3H, C-6CHCH3), 0.93 (d, J = 6.9, 3H,
C-3CH2CHCH3), 0.94 (d, J = 6.8, 3H, C-5CH2CHCH3), 0.98
(d, J = 6.7, 3H, C-6CHCH3), 1.30 (ddd, J = 13.9, 7.1, 6.5, 1H,
C-5CH2), 1.33 (ddd, J = 13.9, 8.2, 5.6, 1H, C-5CH2), 1.40 (ddd,
J = 14.2, 10.0, 4.1, 1H, C-3CH2), 1.65 (nonet, J = 6.7, 1H,
C-5CH2CH), 1.74 (m, 1H, C-3CH2CH), 1.88 (ddd, J = 13.7,
10.3, 3.3, 1H, C-3CH2), 1.91 (hepd, J = 6.8, 2.5, 1H, C-6CH),
3.06 (dd, J = 6.7, 3.6, 1H, C-6H), 3.15 (dt, J = 7.8, 5.3, 1H,
C-5H), 3.40 (dd, J = 10.2, 3.4, 1H, C-3H), 6.22 (brs, 1H, N1H),
N4H peak is missing; 13C NMR (125 MHz, CDCl3) δ 17.7
(C-6CHCH3), 21.0 (C-3CH2CHCH3), 21.5 (C-5CH2CHCH3),
22.4 (C-6CHCH3) ,  23.1 and 23.7 (C-3CH2CHCH3 /
C-5CH2CHCH3), 24.4 (C-3CH2CH), 24.8 (C-5CH2CH), 27.9
(C-6CH), 40.5 (C-5CH2), 41.1 (C-3CH2), 53.3 (C-5), 57.0
(C-3), 59.4 (C-6), 174.2 (C=O); MS (EI+) m/z: 254 (M+, 30%),
197 (22%), 169 (43%), 154 (31%); HRMS m/z: calcd for
C15H30N2O, 254.2353; found, 254.2355.
1H NMR (600 MHz, DMSO-d6) δ 0.83–0.89 (m, 18H, 6xMe),
1.25 (m, 3H, C-3CH2 + 2xC-5CH2), 1.65 (m, 2H, C-3CH2CH +
C-5CH2CH), 1.79 (m, 2H, C-3CH2 + C-6CH), 2.90 (brd, J =
3.2, 1H, C-6H), 3.01 (td, J = 7.1, 3.7, 1H, C-5H), 3.21 (dd, J =
9.3, 3.2, 1H, C-3H), 7.63 (brs, 1H, NH). Assignments based on
above; 13C NMR (125 MHz, DMSO-d6) δ 18.4, 21.5, 22.0,
22.8, 23.0, 23.8, 23.9, 24.2, 27.4, 40.2, 41.5, 53.2, 56.4, 58.1,
172.5.
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In a clean vial HCl in dioxane (~1 equiv) was added to a small
sample of 2 in MeCN, the mixture layered with Et2O and then
left in the fridge until colourless blades of 2·HCl had formed at
the interface. mp 121–123 °C. 1H NMR (600 MHz, D2O) δ
0.89–0.99 (6xMe), 1.52–1.68 (m, 4H), 1.72–1.79 (m, 1H),
1.94–1.99 (m, 2H), 3.50 (dd, J = 6.2, 4.3, 1H, C-6H), 3.79 (m,
1H, C-5H), 4.01 (dd, J = 8.3, 5.3, 1H, C-3H); 13C NMR (150
MHz, D2O) δ 18.8, 20.6, 21.3, 22.0, 22.5, 24.2, 24.7, 25.7, 27.4,
36.3, 38.8, 53.9, 54.9, 56.3, 169.9 (C=O).
Supporting Information
Supporting Information File 1
Further experimental and characterisation data.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-9-200-S1.pdf]
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